Key result
Higher modifiable CV risk burden is linked to stepwise increases in culprit plaque vulnerability in ACS.
Why the study?
Cardiovascular risk factors and coronary plaque vulnerability both associate with adverse cardiovascular outcomes, but have evolved along largely separate tracks.
Is modifiable cardiovascular risk factor burden associated with coronary plaque vulnerability assessed by OCT in patients with ACS?
Is modifiable cardiovascular risk factor burden associated with coronary plaque vulnerability assessed by OCT in patients with ACS?
Cumulative modifiable cardiovascular risk factor burden correlates with OCT-defined coronary plaque vulnerability in ACS patients, linking epidemiological risk with plaque biology.
May inform integrated risk-plaque assessment in ACS; leaves open whether modification alters vulnerability or outcomes.
Purpose of review Both cardiovascular risk factors and features of coronary plaque vulnerability are associated with adverse cardiovascular outcomes, including acute coronary syndromes (ACS); however, these epidemiological and pathological concepts have evolved along largely separate tracks. This review discusses emerging evidence that modifiable cardiovascular risk factor burden is associated with plaque vulnerability, as assessed by optical coherence tomography (OCT). Recent findings Recent large-scale OCT analyses suggest that, in patients with ACS, increasing modifiable cardiovascular risk factor burden is associated with a stepwise increase in culprit plaque features of vulnerability, including lipid-rich plaque, thin-cap fibroatheroma, macrophage accumulation, microvessels, and cholesterol crystals. This association was weaker in nonculprit plaques. In contrast, nonmodifiable risk factor burden was not associated with plaque vulnerability. These findings extend previous studies of individual risk factors by showing that cumulative modifiable risk burden is reflected in plaque phenotype. Summary Current evidence supports the concept that cumulative modifiable cardiovascular risk factor burden may reflect coronary plaque biology, linking epidemiological risk assessment with imaging-defined plaque vulnerability. In this framework, cardiovascular risk factor burden may be understood as a surrogate of plaque vulnerability, linked to inflammatory, oxidative, and metabolic pathways. This association may help identify higher risk patients.
No takes yet. Share an insight, caveat, or question.
Chmiel et al. (2026) conducted a review in Acute coronary syndromes (ACS). Modifiable cardiovascular risk factor burden was evaluated on Plaque vulnerability (lipid-rich plaque, thin-cap fibroatheroma, macrophage accumulation, microvessels, and cholesterol crystals). Increasing modifiable cardiovascular risk factor burden is associated with a stepwise increase in culprit plaque features of vulnerability in patients with acute coronary syndromes.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: